EMAN BEAUTY LAB LTD

Company number 12926473 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

EMAN BEAUTY LAB LTD - Analysis Report

Company Number: 12926473

Analysis Date: 2025-07-29 14:37 UTC

  1. Risk Rating: HIGH
    The company's financials reveal substantial and growing negative net current assets and shareholders' funds, indicating a significant solvency risk. Current liabilities vastly exceed current assets, and there is a heavy reliance on director loans, raising concerns about liquidity and financial stability.

  2. Key Concerns:

  • Solvency Risk: Negative shareholders' funds of £123,318 (2023) worsening from £78,958 (2022) highlight ongoing losses and potential inability to meet long-term obligations.
  • Liquidity Concerns: Current liabilities of £255,694 against minimal current assets (£1,940) and cash (£590) indicate severe working capital shortages and cash flow constraints.
  • Reliance on Director Loan: Over £255k owed to a director, a substantial portion of liabilities, suggests dependence on related party funding which may not be sustainable or easily recoverable.
  1. Positive Indicators:
  • Active Operations: The company is actively trading with an up-to-date confirmation statement and accounts filed on time, indicating regulatory compliance.
  • Tangible Fixed Assets: The company holds tangible fixed assets with a net book value of £130,436, showing investment in operational infrastructure.
  • Going Concern Statement: The director has confirmed ongoing financial support, which may provide short-term stability.
  1. Due Diligence Notes:
  • Investigate the nature and terms of the director loan including repayment schedule and security.
  • Review cash flow forecasts and management plans to address the negative working capital position.
  • Confirm trading performance and profitability trends beyond balance sheet snapshots, including turnover and margins.
  • Assess potential risks related to the concentration of control between two PSCs, especially with a director having resigned in 2022.
  • Verify absence of any overdue filings or regulatory issues beyond what is reported.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.